ZND-16337-01863
3 vaccinations
6 coded responses
31 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 474 / IN
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2021-01-07
Registered in v-safe
- 2021-01-07
- 2021-01-11
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-26
- 2021-02-03
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-04-13
- 2021-07-13
-
2021-09-26
Dose 3 — Pfizer-BioNTech
-
2021-09-27
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tirednessAdult check-in
-
2021-09-28
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: PainFree text: Left supraclavicular lymph node swelling and painMedDRA releases: 2024-11 · check-in free text available
-
2021-09-29
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: PainFree text: Left supraclavicular lymph node swelling and pain (better than yesterday)MedDRA releases: 2024-11 · check-in free text available
-
2021-10-01
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Left supraclavicular lymph node swelling (mild)MedDRA releases: 2024-11 · check-in free text available
- 2021-10-02
- 2021-10-03
- 2021-10-10
-
2021-10-17
Survey response — day 21, dose 3MedDRA: Anosmia, Brain fog, Decreased appetite, Fatigue, Paranasal sinus discomfort, Sinusitis, Sneezing — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sinus infection - sinus pressure, sneezing, brain fog, fatigue, loss of smell and appetiteMedDRA releases: 2024-11 · check-in free text available
- 2021-10-26
- 2021-10-31
- 2021-11-07
-
2021-12-26
Survey response — 3 months, dose 3MedDRA: Bronchitis, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Bronchitis - negative COVID tests x2MedDRA releases: 2024-11 · check-in free text available
- 2022-03-27
-
2022-09-26
Survey response — 12 months, dose 3MedDRA: COVID-19, Conjunctivitis, Cough, Headache, Malaise, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVID symptoms 8.26.22 - dry cough, conjunctivitis, slight runny nose, headache. Treated with Paxlovid, positive 12 days.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-26
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-09-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-09-26 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-09-26 | Unsuccessful |
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Left supraclavicular lymph node swelling and pain
Systemic reaction (other): Left supraclavicular lymph node swelling and pain (better than yesterday)
Systemic reaction (other): Left supraclavicular lymph node swelling (mild)
Release 10 — day 21, dose 3
Symptoms: Sinus infection - sinus pressure, sneezing, brain fog, fatigue, loss of smell and appetite
Release 10 — 3 months, dose 3
Symptoms: Bronchitis - negative COVID tests x2
Release 12 — 12 months, dose 3
Symptoms: COVID symptoms 8.26.22 - dry cough, conjunctivitis, slight runny nose, headache. Treated with Paxlovid, positive 12 days.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Bronchitis | · | · | ✓ |
| SD | Conjunctivitis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release